Precigen, Inc.
PGEN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356090
In the last 90 days, Precigen, Inc. insiders filed 1 open-market purchase and 6 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $799.4M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Precigen, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- −6 vs. Q4 2023
- Shares held
- 61.6M
- −918.4K (−1.5%) vs. Q4 2023
- Total value
- $89.4M
- +$5.52M (+6.6%) vs. Q4 2023
- New holders
- 9
- 34 more added
- Sold out
- 15
- 46 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 210 | $799.4M |
| Q1 2026 | 206 | $516.7M |
| Q4 2025 | 179 | $568.5M |
| Q3 2025 | 167 | $366.2M |
| Q2 2025 | 147 | $116.6M |
| Q1 2025 | 138 | $119.3M |
| Q4 2024 | 133 | $84.8M |
| Q3 2024 | 127 | $71.7M |
| Q2 2024 | 130 | $95.9M |
| Q1 2024 | 129 | $89.4M |
| Q4 2023 | 137 | $83.9M |
| Q3 2023 | 138 | $86.0M |
| Q2 2023 | 138 | $66.0M |
| Q1 2023 | 157 | $65.1M |
| Q4 2022 | 161 | $64.3M |
| Q3 2022 | 165 | $265.0M |
| Q2 2022 | 169 | $182.2M |
| Q1 2022 | 173 | $302.8M |
| Q4 2021 | 168 | $529.9M |
| Q3 2021 | 172 | $690.3M |
| Q2 2021 | 150 | $926.2M |
| Q1 2021 | 166 | $978.6M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Precigen, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Exchange Traded Concepts, LLC | 199,255 | $288.9K | 0.01% | +105,164+111.8% | Added |
| Rhumbline Advisers | 203,137 | $294.5K | 0.00% | −4,863−2.3% | Reduced |
| Gsa Capital Partners LLP | 223,288 | $324.0K | 0.03% | −348,175−60.9% | Reduced |
| FMR LLC | 255,635 | $370.7K | 0.00% | −281−0.1% | Reduced |
| Cetera Investment Advisers | 260,512 | $377.7K | 0.00% | +8,937+3.6% | Added |
| Goldman Sachs Group Inc | 284,436 | $412.4K | 0.00% | −634−0.2% | Reduced |
| Advisor Group Holdings, Inc. | 298,642 | $433.0K | 0.00% | −13,436−4.3% | Reduced |
| Fore Capital, LLC | 306,791 | $444.8K | 0.81% | −50,000−14.0% | Reduced |
| Citadel Advisors LLC | 317,256 | $460.0K | 0.00% | −214,264−40.3% | Reduced |
| MSD Partners, L.P. | 355,000 | $514.8K | 0.04% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 402,487 | $583.6K | 0.00% | −43,914−9.8% | Reduced |
| ClariVest Asset Management LLC | 478,400 | $693.7K | 0.07% | +895+0.2% | Added |
| Emfo, LLC | 519,475 | $753.2K | 0.69% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 534,983 | $775.7K | 0.00% | 00.0% | Unchanged |
| Sanders Morris Harris LLC | 705,000 | $1.02M | 0.19% | +705,000 | New |
| Opaleye Management Inc. | 947,500 | $1.37M | 0.30% | −65,000−6.4% | Reduced |
| Renaissance Technologies LLC | 1,052,190 | $1.53M | 0.00% | +177,887+20.3% | Added |
| Morgan Stanley | 1,063,328 | $1.54M | 0.00% | −200,981−15.9% | Reduced |
| Charles Schwab Investment Management Inc | 1,068,527 | $1.55M | 0.00% | +59,109+5.9% | Added |
| Northern Trust Corp | 1,082,317 | $1.57M | 0.00% | −1350.0% | Reduced |
| JPMorgan Chase & Co | 1,294,704 | $1.88M | 0.00% | −48,572−3.6% | Reduced |
| Millennium Management LLC | 1,370,451 | $1.99M | 0.00% | −1,475,460−51.8% | Reduced |
| D. E. Shaw & Co., Inc. | 1,784,886 | $2.59M | 0.00% | +775,439+76.8% | Added |
| Iridian Asset Management LLC | 2,091,274 | $3.03M | 0.59% | +86,340+4.3% | Added |
| State Street Corp | 2,825,450 | $4.10M | 0.00% | +140,917+5.2% | Added |
| Geode Capital Management, LLC | 3,030,885 | $4.40M | 0.00% | +9,588+0.3% | Added |
| Vanguard Group Inc | 6,768,234 | $9.81M | 0.00% | +19,875+0.3% | Added |
| BlackRock Inc. | 10,363,128 | $15.0M | 0.00% | −756,992−6.8% | Reduced |
| Patient Capital Management, LLC | 17,453,455 | $25.3M | 1.23% | +1,469,755+9.2% | Added |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −373,013−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −90,561−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −66,162−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −48,518−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −46,459−100.0% | Sold out |
| Fisher Asset Management, LLC | 0 | $0 | 0.00% | −21,800−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −16,393−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −15,758−100.0% | Sold out |
| Congress Wealth Management LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,949−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −10,357−100.0% | Sold out |
| Flower City Capital | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| WFA Asset Management Corp | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Sawtooth Solutions, LLC | – | – | – | – | Not filed |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |